<DOC>
	<DOCNO>NCT01365819</DOCNO>
	<brief_summary>Methamphetamine ( MA ) dependence source continue danger individual society . While behavioral treatment , always effective . To date , medication available treatment methamphetamine dependence . There early evidence suggest varenicline ( also know Chantix ( tm ) ) may help people stop reduce use methamphetamine . Varenicline already market U.S. cigarette smoking cessation show promise treat alcohol dependence . In order determine varenicline help people stop use methamphetamine , enroll 90 methamphetamine-dependent people look treatment study UCLA Vine Street Clinic operate Dr Shoptaw UCLA . Half receive varenicline ( n=45 ) half receive placebo ( n=45 ) determine randomly . Everyone receive talk therapy methamphetamine dependence . People take medication 9 week follow 4 week follow-up period . Before receive medication , participant complete maximum 2 week ( 6 study visit ) lead-in complete baseline assessment , psychological medical evaluation , comprehensive assessment drug use determine study eligibility . If person eligible study , s/he receive either varenicline placebo . Participants visit UCLA Vine Street Clinic ( UCLA VSC ) three time week study visit . At end medication phase , subject complete four week follow period safety monitoring .</brief_summary>
	<brief_title>Varenicline Methamphetamine Dependence</brief_title>
	<detailed_description>Methamphetamine ( MA ) dependence significant source deleterious consequence individual public health include HIV infection , psychological distress , cardiovascular disease . Behavioral treatment , include cognitive behavioral therapy contingency management available , modestly effective . Although pharmacotherapy may improve treatment outcome , ten year randomize , placebo-controlled trial medication MA dependence fail identify medication robust effect generalize population MA user . Cholinergic mechanisms important neurobiology MA dependence . Varenicline α4β2 nicotinic receptor partial agonist α7 nicotinic receptor full agonist approve cigarette smoke cessation show promise treat alcohol dependence . Varenicline may effective treatment MA dependence due : ( 1 ) restoration MA-related dopaminergic deficit via bind α4β2 receptor striatal dopaminergic ( DA ) neuron , ( 2 ) reduction cigarette smoke associate nicotine-mediated potentiation MA effect , ( 3 ) activation nicotinic cholinergic system mediate reduction reinstatement MA seek see cannabinoid receptor antagonist acetylcholinesterase inhibitor , ( 4 ) relief MA-related glutamatergic deficit via α7 nicotinic acetylcholine ( ACh ) receptor activation , ( 5 ) reduction MA-related cognitive dysfunction via cognitive enhance effect cholinergic agonist . The investigator enroll 90 treatment seek , MA-dependent participant randomly assign receive varenicline ( n=45 ) placebo ( n=45 ) , conjunction cognitive behavioral therapy ( CBT ) 9 week follow 4 week follow-up period . Prior enrollment trial , participant complete maximum 2 week ( 6 study visit ) lead-in complete baseline assessment , psychological medical evaluation , comprehensive assessment drug use determine study eligibility . Once determine eligible trial , participant randomly assign varenicline placebo start study medication . Similar smoke cessation treatment , participant undergo dose escalation varenicline 1 mg BID ( placebo BID ) one week outpatient . Participants regular clinic visit UCLA Vine Street Clinic ( UCLA VSC ) thrice-weekly study visit . At end medication phase , subject complete four-week follow period safety monitoring .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Contact site additional information . Contact site additional information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Crystal meth dependence</keyword>
	<keyword>crystal meth</keyword>
	<keyword>methamphetamine dependence</keyword>
	<keyword>substance abuse</keyword>
</DOC>